Risk stratification in nonischemic dilated cardiomyopathy: Current perspectives

Cardiology Journal

Volumn 17, Issue 3, 2010, Pages 219-229

  Okutucu, Sercan ^a   Oto, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Nonischemic cardiomyopathy; Risk stratification; Sudden cardiac death

Indexed keywords

AMIODARONE; GADOLINIUM; PLACEBO;

AMBULATORY MONITORING; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; EVENT FREE SURVIVAL; HEART ARREST; HEART BUNDLE BRANCH BLOCK; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; NONLINEAR SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRESSORECEPTOR REFLEX; PROGNOSIS; QRS COMPLEX; QT DISPERSION; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; SYNCOPE; T WAVE INVERSION; CARDIOMYOPATHY, DILATED; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEART FUNCTION TEST; HEART PACING; HEART RATE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; TIME;

BAROREFLEX; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART RATE; HUMANS; MAGNETIC RESONANCE IMAGING; NONLINEAR DYNAMICS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SYNCOPE; TIME FACTORS;

EID: 77953334825     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med, 1994; 331: 1564-1575.
2. Manolio TA, Baughman KL, Rodeheffer R et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am J Cardiol, 1992; 69: 1458-1466.
3. Kitamura H, Ohnishi Y, Okajima K et al. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol, 2002; 39: 295-300.
4. Goldberger JJ, Cain ME, Hohnloser SH et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Heart Rhythm, 2008; 5: e1-e21.
5. Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J, 2006; 27: 2099-2140.
6. Zareba W. Holter electrocardiogram parameters in risk stratification of arrhythmic events in idiopathic dilated cardiomyopathy: More studies are needed. J Am Coll Cardiol, 2007; 50: 232-233.
7. Singh SK, Link MS, Wang PJ, Homoud M, Estes NA 3rd. Syncope in the patient with nonischemic dilated cardiomyopathy. Pacing Clin Electrophysiol, 2004; 27: 97-100.
8. Knight BP, Goyal R, Pelosi F et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol, 1999; 33: 1964-1970.
9. Middlekauff HR, Stevenson WG, Stevenson LW, Saxon LA. Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope. J Am Coll Cardiol, 1993; 21: 110-116.
10. Brembilla-Perrot B, Donetti J, de la Chaise AT, Sadoul N, Aliot E, Juilliere Y. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J, 1991; 121 (4 Part 1): 1124-1131.
11. Fruhwald FM, Eber B, Schumacher M, Zweiker R, Watzinger N, Klein WW. Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death. Cardiology, 1996; 87: 177-180.
12. Phang RS, Kang D, Tighiouart H, Estes NAM, Link MS. High risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope. Am J Cardiol, 2006; 97: 416-420.
13. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. J Am Coll Cardiol, 2008; 51: e1-e62.
14. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med, 1989; 321: 406-412.
15. Waldo AL, Camm AJ, deRuyter H et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet, 1996; 348: 7-12.
16. Doval HC, Nul DR, Grancelli HO et al. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation, 1996; 94: 3198-3203.
17. Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med, 1995; 333: 77-82.
18. Meinertz T, Hofmann T, Kasper W et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol, 1984; 53: 902-907.
19. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol, 1984; 54: 147-152.
20. von Olshausen K, Schafer A, Mehmel HC, Schwarz F, Senges J, Kubler W. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J, 1984; 51: 195-201.
21. Costanzo-Nordin MR, O'Connell JB, Engelmeier RS, Moran JF, Scanlon PJ. Dilated cardiomyopathy: functional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc Diagn, 1985; 11: 445-453.
22. Iacoviello M, Forleo C, Guida P et al. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 2007; 50: 225-231.
23. Baker RL, Koelling TM. Prognostic value of ambulatory electrocardiography monitoring in patients with dilated cardiomyopathy. J Electrocardiol, 2005; 38: 64-68.
24. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation, 2003; 108: 2883-2891.
25. Grimm W, Christ M, Maisch B. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol, 2005; 28 (suppl. 1): S207-S210.
26. Becker R, Haass M, Ick D et al. Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol, 2003; 98: 259-266.
27. Meinertz T, Treese N, Kasper W et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol, 1985; 56: 337-341.
28. Stamato NJ, O'Connell JB, Murdock DK, Moran JF, Loeb HS, Scanlon PJ. The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation. Am Heart J, 1986; 112: 505-508.
29. Hammill SC, Trusty JM, Wood DL et al. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Am J Cardiol, 1990; 65: 722-728.
30. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol, 1998; 32: 739-745.
31. Shenkman HJ, Pampati V, Khandelwal AK et al. Congestive heart failure and QRS duration: Establishing prognosis study. Chest, 2002; 122: 528-534.
32. Baldasseroni S, Opasich C, Gorini M et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J, 2002; 143: 398-405.
33. Silverman ME, Pressel MD, Brackett JC, Lauria SS, Gold MR, Gottlieb SS. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol, 1995; 75: 460-464.
34. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237.
35. Dhar R, Alsheikh-Ali AA, Estes NAM et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm, 2008; 5: 807-813.
36. Kadish A, Dyer A, Daubert JP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med, 2004; 350: 2151-2158.
37. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol, 2000; 36: 1749-1766.
38. Galinier M, Vialette JC, Fourcade J et al. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J, 1998; 19: 1054-1062.
39. Fei L, Goldman JH, Prasad K et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J, 1996; 17: 258-263.
40. Grimm W, Steder U, Menz V, Hoffmann J, Grote F, Maisch B. Clinical significance of increased OT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy. Pacing Clin Electrophysiol, 1996; 19 (11 Part 2): 1886-1889.
41. Fauchier L, Douglas J, Babuty D, Cosnay P, Fauchier JP. QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluation. Eur J Heart Fail, 2005; 7: 277-282.
42. Stein KM. Noninvasive risk stratification for sudden death: Signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration. Prog Cardiovasc Dis, 2008; 51: 106-117.
43. Marcus FI, Zareba W, Sherrill D. Evaluation of the normal values for signal-averaged electrocardiogram. J Cardiovasc Electrophysiol, 2007; 18: 231-233.
44. Fauchier L, Babuty D, Cosnay P, Poret P, Rouesnel P, Fauchier JP. Long-term prognostic value of time domain analysis of signal-- veraged electrocardiography in idiopathic dilated cardiomyopathy. Am J Cardiol, 2000; 85: 618-623.
45. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation, 1993; 87: 1083-1092.
46. Turitto G, Ahuja RK, Caref EB, el-Sherif N. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram. J Am Coll Cardiol, 1994; 24: 1523-1528.
47. Galinier M, Albenque JP, Afchar N et al. Prognostic value of late potentials in patients with congestive heart failure. Eur Heart J, 1996; 17: 264-271.
48. Adachi K, Ohnishi Y, Yokoyama M. Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt--level T-wave alternans. Jpn Circ J, 2001; 65: 76-80.
49. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol, 2003; 41: 2220-2224.
50. Bloomfield DM, Bigger JT, Steinman RC et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol, 2006; 47: 456-463.
51. Salerno-Uriarte JA, De Ferrari GM, Klersy C et al. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study. J Am Coll Cardiol, 2007; 50: 1896-1904.
52. De Ferrari GM, Sanzo A. T-wave alternans in risk stratification of patients with nonischemic dilated cardiomyopathy: Can it help to better select candidates for ICD implantation? Heart Rhythm, 2009; 6 (3 suppl.): S29-S35.
53. Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: Characteristics and prognostic value. J Am Coll Cardiol, 1997; 30: 1009-1014.
54. Yi G, Goldman JH, Keeling PJ, Reardon M, McKenna WJ, Malik M. Heart rate variability in idiopathic dilated cardiomyopathy: Relation to disease severity and prognosis. Heart, 1997; 77: 108-114.
55. Nolan J, Batin PD, Andrews R et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation, 1998; 98: 1510-1516.
56. Rashba EJ, Estes NA, Wang P et al. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial. Heart Rhythm, 2006; 3: 281-286.
57. Miwa Y, Ikeda T, Sakaki K et al. Heart rate turbulence as a predictor of cardiac mortality and arrhythmic events in patients with dilated cardiomyopathy: a prospective study. J Cardiovasc Electrophysiol, 2009; 20: 788-795.
58. Grimm W, Schmidt G, Maisch B, Sharkova J, Muller HH, Christ M. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol, 2003; 14: 819-824.
59. Cygankiewicz I, Zareba W, Vazquez R et al. Relation of heart rate turbulence to severity of heart failure. Am J Cardiol, 2006; 98: 1635-1640.
60. Klingenheben T, Ptaszynski P, Hohnloser SH. Heart rate turbulence and other autonomic risk markers for arrhythmia risk stratification in dilated cardiomyopathy. J Electrocardiol, 2008; 41: 306-311.
61. Mortara A, La Rovere MT, Pinna GD et al. Depressed arterial baroreflex sensitivity and not reduced heart rate variability identifies patients with chronic heart failure and nonsustained ventricular tachycardia: the effect of high ventricular filling pressure. Am Heart J, 1997; 134 (5 Part 1): 879-888.
62. Vivekananthan DP, Blackstone EH, Pothier CE, Lauer MS. Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol, 2003; 42: 831-838.
63. Arena R, Guazzi M, Myers J, Peberdy MA. Prognostic value of heart rate recovery in patients with heart failure. Am Heart J, 2006; 151: 851 e857-e813.
64. Imai K, Sato H, Hori M et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. J Am Coll Cardiol, 1994; 24: 1529-1535.
65. O'Neill JO, Young JB, Pothier CE, Lauer MS. Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure. J Am Coll Cardiol, 2004; 44: 820-826.
66. Das MK, Zipes DP. Fragmented QRS: A predictor of mortality and sudden cardiac death. Heart Rhythm, 2009; 6 (3 suppl.): S8-S14.
67. Michael MA, Das MK. Fragmented QRS on 12-lead ECG predicts arrhythmic event and mortality in patient with non-ischemic cardiomyopathy. Heart Rhythm, 2006; 3: S103-S104.
68. Hombach V, Grebe O, Merkle N et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J, 2005; 26: 549-557.
69. Wu KC, Weiss RG, Thiemann DR et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Cardiol, 2008; 51: 2414-2421.
70. Hombach V, Merkle N, Torzewski J et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J, 2009; 30: 2011-2018.
71. Goldberger AL, Amaral LAN, Glass L et al. PhysioBank, Physio- Toolkit, and PhysioNet: Components of a new research resource for complex physiologic signals. Circulation, 2000; 101: E215--E220.
72. Glass L, Lerma C. Risk stratification for arrhythmic sudden cardiac death. Heart Rhythm, 2006; 3: 1497-1501.